Exchange: NASDAQ·Updated 07:30 PM EST
INDP logo

INDP Indaptus Therapeutics Inc

$2.96
$0.31
(9.90%)
Today
Closed $2.82
$0.14
(4.96%)
After Hours
Mkt Cap$433.16M
Vol239,363.00

About INDP

Indaptus Therapeutics, Inc. is a clinical biotechnology company. The firm engages in the development of a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It created patented treatment methods and associated patented compositions for attenuation and killing of non-pathogenic, Gram-negative bacteria. The company was founded by Michael James Newman on February 24, 2021 and is headquartered in New York, NY.
45

Neutral Sentiment

How do you feel about INDP?

TwongStocks
$INDP 10-Q filed https://www.sec.gov/Archives/edgar/data/1857044/000149315226051550/form10-q.htm • 153,602,583 shares outstanding as of Nov 13. • As of September 30, 2026, had cash of $26.6M & short-term investments of $4.0M. Management believes that existing cash and short-term investments, together with the $3.5M received in October 2026, will be sufficient to fund the Company’s operating expenses and capital expenditure requirements through the year ended December 31, 2027. • See screenshot for current clinical updates. • Net loss last quarter was ($1.05M).

Advertisement|Remove ads.